Intoxication Associated with Ayahuasca Consumption, Characterization, and Comparative Analysis of the Beverage's Components: A Case Report

Ayala, 1978, Drinking the South American hallucinogenic ayahuasca, Econ Bot, 32, 154, 10.1007/BF02866869 Estrella, 2019, Ayahuasca: uses, phytochemical and biological activities, Nat Prod Bioprospect, 9, 251, 10.1007/s13659-019-0210-5 Winkelman, 2005, Drug tourism or spiritual healing? Ayahuasca seekers in Amazonian, J Psychoactive Drugs, 37, 209, 10.1080/02791072.2005.10399803 Frecska, 2016, The therapeutic potentials of ayahuasca: possible effects against various diseases of civilization, Front Pharmacol, 7, 1, 10.3389/fphar.2016.00035 Loizaga, 2014, Therapeutic effect of ritual ayahuasca use in the treatment of substance dependence – qualitative results, J Psychoactive Drugs, 46, 63, 10.1080/02791072.2013.873157 Bouso, 2015, Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans, Eur Neuropsychopharmacol, 25, 483, 10.1016/j.euroneuro.2015.01.008 McKenna, 2004, Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges, Pharmacol Ther, 102, 111, 10.1016/j.pharmthera.2004.03.002 Riba, 2001, Subjective effects and tolerability of the South American psychoactive beverage ayahuasca in healthy volunteers, Psychopharmacology (Berl), 154, 85, 10.1007/s002130000606 Cavnar, 2014, The effects of ayahuasca ritual participation on gay and lesbian identity, J Psychoactive Drugs, 46, 252, 10.1080/02791072.2014.920117 Kuypers, 2016, Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking, Psychopharmacology (Berl), 233, 3395, 10.1007/s00213-016-4377-8 Mabit, 2007, Ayahuasca in the treatment of addictions, vol. 2, 87 Kjellgren, 2009, Experiences of encounters with ayahuasca – “the vine of the soul”, J Psychoactive Drugs, 41, 309, 10.1080/02791072.2009.10399767 Gable, 2007, Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids, Addiction, 102, 24, 10.1111/j.1360-0443.2006.01652.x Shanon, 2003, Altered states and the study of consciousness – the case of ayahuasca, J Mind Behav, 24, 125 Riba, 2003, Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics, J Pharmacol Exp Ther, 306, 73, 10.1124/jpet.103.049882 Palma, 2021, Psychosis induced by abuse of ayahuasca: a case report, Rev Colomb Psiquiat, 50, 43 Dos Santos, 2013, Safety and side effects of ayahuasca in humans – an overview focusing developmental toxicology, J Psychoactive Drugs, 45, 68, 10.1080/02791072.2013.763564 Callaway, 1998, Ayahuasca preparations and serotonin reuptake inhibitors: a potential combination for severe adverse interactions, J Psychoactive Drugs, 30, 367, 10.1080/02791072.1998.10399712 Kawanishi, 1994, Relationship between occurrence of tremor/convulsion and level of beta-carbolines in the brain after administration of beta-carbolines into mice, Pharmacol Biochem Behav, 47, 689, 10.1016/0091-3057(94)90175-9 Shoptaw, 2022, Frequency of reported methamphetamine use linked to prevalence of clinical conditions, sexual risk behaviors, and social adversity in diverse men who have sex with men in Los Angeles, Drug Alcohol Depend, 232, 109320, 10.1016/j.drugalcdep.2022.109320 Kulacaoglu, 2021, Psychotic mania induced by disulfiram: a case report and review, Eur Neuropsychopharm, 53, S159, 10.1016/j.euroneuro.2021.10.210 IHCPC. Information for Health Care Professionals Cannabis (marihuana, marijuana) and the cannabinoids. Prepared by Health Canada. Date of latest version: February 2013. FDA, 2022a. Approved Drug Products: EQUETRO (carbamazepine) extended-release capsules. Reference ID: 3989939. FDA, 2022b. Approved Drug Products: Valium (Diazepam) Tablets. Reference ID: 4029651. Linardi, 2015, Ritualistic use of ayahuasca versus street use of similar substances seized by the police: a key factor involved in the potential for intoxications and overdose?, J Psychoactive Drugs, 47, 132, 10.1080/02791072.2015.1013202 Umut, 2011, A mood disorder episode with an onset under chronic cannabis consumption and accompanied with psychotic features immediately after N,N-dimethyltryptamine (DMT) use: case report, Düşünen Adam J Psychiatric Neurol Sci, 24, 246 Wiltshire, 2015, Light microscopy can reveal the consumption of a mixture of psychotropic plant and fungal material in suspicious death, J Foren Legal Med, 34, 73, 10.1016/j.jflm.2015.05.010 Szmulewicz, 2015, Switch to mania after ayahuasca consumption in a man with bipolar disorder: a case report, Int J Bipolar Dis, 3, 1 Tupper, 2009, Ayahuasca healing beyond the Amazon: the globalization of a traditional indigenous entheogenic practice, Global Networks, 9, 117, 10.1111/j.1471-0374.2009.00245.x Beyer, 2012, Special ayahuasca issue introduction: toward a multidisciplinary approach to ayahuasca studies, Anthropol Conscious, 23, 1, 10.1111/j.1556-3537.2012.01053.x